The tweet was deleted by the author.
But we saved everything 🙂.
Cencora is promoting the adoption of innovation, operational optimization and advocacy for change among pharmacy leaders, according to a tweet referencing a column by Matt Glucksmann in MedCityNews.
The tweet states that these efforts can help organizations prepare for the future and actively shape it. Details are available via a linked article.
COR (Cencora) is trading at $318.03, notably below its SMA-20 ($346.22), SMA-50 ($352.69), and SMA-200 ($325.61), confirming strong short-, medium-, and long-term pressure from sellers. The Ichimoku Kijun on D1 stands at $346.89, marking immediate resistance for the price. Near-term support lies at SMA-200 ($325.61), followed by SMA-100 ($351.05) as key resistance, while the Ichimoku Kijun ($346.89) and SMA-50 ($352.69) represent additional resistance levels further above current levels.
Momentum signals are dominantly bearish, as MACD on D1 is negative and ADX indicates a sell bias, highlighting a downtrending environment. Oscillators such as RSI (31.31), Stoch RSI (14.73), CCI (–110.97), and BBP on D1 all indicate oversold conditions, while BBP confirms persistent dominance by sellers throughout intraday trading. In today’s session, Cencora dropped 2.17% as further downside accelerated, and over the past week, the stock has fallen $8.88 (2.72%) from a previous weekly close of $326.91. The current price is at the very bottom of the weekly range, with volatility at 4.99%, signaling a steady decline from the recent high aligned with bearish momentum.
Looking ahead, the expected price corridor for the coming week is $315 to $328, reflecting the most likely scenario and remaining within 52-week bounds of $267.40 to $377.54. With only one out of four W1 trend indicators (MACD W1) showing a "Strong Buy" while RSI W1, ADX W1, and MA-50 W1 all point to "Sell," there is a very low probability (less than 20%) of a sustained upward move, making further declines more likely. Baseline scenario: price consolidates in the $315–$328 band as sideways action persists. Bullish scenario: a close above $328 would target immediate resistance at the Ichimoku Kijun ($346.89). Bearish scenario: a confirmed drop below $315 could expose the stock to new downside risk toward longer-term support, though selling may moderate as oversold signals are already severe.